Scientists Want to Create a New Kind of Mosquito

Photo: Courtesy of Luciano Moreira, Anil Ghosh, Marcelo Jacobs-Lorena NEW LARVAE ON THE BLOCK: Transgenic and nontransgenic Anopheles stephensi larvae. The latter is recognizable by its green-glowing eyes, thanks to green fluorescent protein. Despite decades of control and treatment efforts, from DDT to antimalarial drugs, more than one million people die from malaria every year and hundreds of millions more become infected. It seems that as soon as a new tool emerges, a new form of resi

Written byLeslie Pray
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Despite decades of control and treatment efforts, from DDT to antimalarial drugs, more than one million people die from malaria every year and hundreds of millions more become infected. It seems that as soon as a new tool emerges, a new form of resistance ensues: DDT-resistant mosquitoes made that pesticide powerless, and the number of drug-resistant parasites is on the rise. Some researchers mused that perhaps it was time to reinvent the mosquito itself, and create bioengineered antimalarial mosquitoes.

A team led by Marcelo Jacobs-Lorena of Case Western Reserve University, Ohio, made a mosquito that blocks the parasite's transmission. They took SM1, a so-called effector gene that interferes with parasite development, and inserted it into the mosquito genome. They then tested the new insect on a murine malarial model. When SM1 is expressed, it prevents the parasite from traversing the mosquito's midgut wall,1 which it must do to continue its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies